July 30, 2021 - ROSEN LOGO.jpg
VERV DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV
24 oct. 2024 20h43 HE | The Rosen Law Firm PA
NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9,...
July 30, 2021 - ROSEN LOGO.jpg
VERV FINAL DEADLINE: RLF, RECOGNIZED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV
22 oct. 2024 20h11 HE | The Rosen Law Firm PA
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino’s, and iLearningEngines and Encourages Investors to Contact the Firm
21 oct. 2024 21h00 HE | Bragar Eagel & Squire
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BL-new-logo.jpg
VERVE THERAPEUTICS, INC. (NASDAQ: VERV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Verve Therapeutics, Inc. Investors of Upcoming Deadline
21 oct. 2024 07h45 HE | Bernstein Liebhard LLP
VERVE THERAPEUTICS, INC. (NASDAQ: VERV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Verve Therapeutics, Inc. Investors of Upcoming Deadline
July 30, 2021 - ROSEN LOGO.jpg
VERV DEADLINE: RLF, THE FIRST FILING FIRM, Encourages Verve Therapeutics, Inc. Investors With Losses in Excess of 100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV
19 oct. 2024 11h57 HE | The Rosen Law Firm PA
NEW YORK, Oct. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino’s, and iLearningEngines and Encourages Investors to Contact the Firm
15 oct. 2024 21h00 HE | Bragar Eagel & Squire
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A TOP RANKED LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV
15 oct. 2024 17h41 HE | The Rosen Law Firm PA
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., October 15, 2024. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc....
BL-new-logo.jpg
VERVE THERAPEUTICS, INC. (NASDAQ: VERV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Verve Therapeutics, Inc. Investors of Upcoming Deadline
14 oct. 2024 08h15 HE | Bernstein Liebhard LLP
VERVE THERAPEUTICS, INC. (NASDAQ: VERV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Verve Therapeutics, Inc. Investors of Upcoming Deadline
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – VERV
11 oct. 2024 19h45 HE | The Rosen Law Firm PA
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9,...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics
11 oct. 2024 10h23 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Verve To Contact Him Directly To Discuss Their Options If...